. Author manuscript; available in PMC: 2023 Jan 1.

Published in final edited form as: J Am Acad Child Adolesc Psychiatry. 2021 Jun 5;61(1):46–55. doi: 10.1016/j.jaac.2021.03.011

Table 4.

Change in Patient and Parent Satisfaction Scores from Baseline to Week 8

Patient satisfaction 8 weeks	Total	TAU	GENE	Treatment difference p-value

Improved	39 (28.1%)	17 (23.6%)	22 (32.8%)	0.143
Did not change	86 (61.9%)	50 (69.4%)	36 (53.7%)
Decreased	14 (10.1%)	5 (6.9%)	9 (13.4%)

Over-all change p-value	0.014	0.034^a	0.028^a

Parent satisfaction 8 weeks

Improved	45 (40.2%)	22 (39.3%)	23 (41.1%)	0.468
Did not change	55 (49.1%)	26 (46.4%)	29 (51.8%)
Decreased	12 (10.7%)	8 (14.3%)	4 (7.1%)

Over-all change p-value	0.0003	0.011^a	0.001^a

Note:

adjusted for multiple comparisons; GENE = Pharmacogenetics guided treatment; TAU = Treatment as usual